ExLibris header image
SFX Logo
Title: Design, Synthesis, and Evaluation of AcyclicC-Nucleoside andN-Methylated Derivatives of the Ribitylaminopyrimidine Substrate of Lumazine Synthase as Potential Enzyme Inhibitors and Mechanistic Probes
Source:

Journal of Organic Chemistry [0022-3263] Chen, Jinhua yr:2004


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. De Clercq, E. "Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections." Clinical microbiology reviews 16.4 (2003): 569-596. Link to Full Text for this item Link to SFX for this item
2. Petersen, Asger B. "Acyclic, achiral enamide nucleoside analogues. The importance of the C = C bond in the analogue for its ability to mimic natural nucleosides." Organic & biomolecular chemistry 1.19 (2003): 3293-3296. Link to Full Text for this item Link to SFX for this item
3. Prommool, V. "A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study." Clinical infectious diseases 48.12 (2009): 1752-9. Link to SFX for this item
4. Van Rompay, Koen K A K. "Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus." Journal of acquired immune deficiency syndromes 43.1 (2006): 6-14. Link to SFX for this item
5. Lennox, Peter L. "Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial." The Lancet 374.9692 (2009): 796-806. Link to SFX for this item
6. Gupta, P. "Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system." Journal of virology 76.19 (2002): 9868-9876. Link to Full Text for this item Link to SFX for this item
7. Cihlar, T. "Nucleotide HIV reverse transcriptase inhibitors: tenofovir and beyond." Current opinion in HIV and AIDS 1.5 (2006): 373-379. Link to SFX for this item
8. Takarinda, Kudakwashe C. "Treatment outcomes of adult patients with recurrent tuberculosis in relation to HIV status in Zimbabwe: a retrospective record review." BMC public health 12.1 (2012): 124-124. Link to Full Text for this item Link to SFX for this item
9. Kozlov, I. "Remote enantioselection transmitted by an achiral peptide nucleic acid backbone." Angewandte Chemie (International ed.) 39.23 (2000): 4292-4295. Link to Full Text for this item Link to SFX for this item
10. Li, Ping g. "Synthesis of Acyclothymidine Triphosphate and α-P-Boranotriphosphate and Their Substrate Properties with Retroviral Reverse Transcriptase." Organic letters 5.14 (2003): 2401-2403. Link to Full Text for this item Link to SFX for this item
11. van den Berg-Wolf, M. "Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons." HIV clinical trials 9.5 (2008): 324-336. Link to SFX for this item
12. Boulle, G. "Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy." JAMA 300.5 (2008): 530-9. Link to SFX for this item
13. Matthews, Sharon R R. "Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy." The journal of infectious diseases 199.7 (2009): 974-81. Link to Full Text for this item Link to SFX for this item
14. Dahl, Britta M. "Improved synthesis of oligonucleotides with an allylic backbone. Oligonucleotides containing acyclic, achiral nucleoside analogs: N-1 or N-9-[3-hydroxy-2-(hydroxymethyl)prop-1-enyl] nucleobases." Organic & biomolecular chemistry 4.6 (2006): 1115-1123. Link to Full Text for this item Link to SFX for this item
15. Guillarme, S. "Rapid access to acyclic nucleosides via conjugate addition." Tetrahedron 59.12 (2003): 2177-2184. Link to SFX for this item
16. Coppola, T. "Synthesis, structural studies and biological properties of new TBA analogues containing an acyclic nucleotide." Bioorganic & medicinal chemistry 16.17 (2008): 8244-53. Link to SFX for this item
17. Cihlar, Gerald R R. "Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors." Antiviral therapy 12.2 (2007): 267-72. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced